India’s own CAR-T cell therapy: What is it, when will it be available, and at what cost? Subject : Science and Tech Section: Health Context: The Central Drugs Standard Control Organisation (CDSCO) granted market authorisation for NexCAR19, India’s first indigenously developed CAR-T cell therapy, to ImmunoACT, a company incubated by IIT Bombay. What […]